Compare · AXP vs CELZ
AXP vs CELZ
Side-by-side comparison of American Express Company (AXP) and Creative Medical Technology Holdings Inc. (CELZ): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AXP and CELZ operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- AXP is the larger of the two at $226.87B, about 27752.5x CELZ ($8.2M).
- AXP has been more active in the news (12 items in the past 4 weeks vs 5 for CELZ).
- AXP has more recent analyst coverage (25 ratings vs 1 for CELZ).
American Express Company
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Latest AXP
- American Express Declares Dividend on Series E Preferred Shares
- Chief Colleague Exp. Officer Herena Monique sold $2,972,920 worth of shares (8,811 units at $337.41), decreasing direct ownership by 41% to 12,445 units (SEC Form 4)
- Food & Wine Best New Chefs Awards Celebration Open to the Public for the First Time in 38-Year History
- American Express to Participate in Barclays Global Financial Services Conference
- American Express Company filed SEC Form 8-K: Regulation FD Disclosure
- American Express Expands Virtual Card Capabilities to Help Businesses Utilize Fast-Growing Commercial Payment Method
- American Express Company filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- American Express Unveils New Tennis Experiences for All Fans and Access to Premium Spaces for Card Members at the 2026 US Open Tennis Championships
- SEC Form N-PX filed by American Express Company
- SEC Form 13F-HR filed by American Express Company
Latest CELZ
- Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
- SEC Form 10-Q filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
- SEC Form 424B3 filed by Creative Medical Technology Holdings Inc.
- SEC Form EFFECT filed by Creative Medical Technology Holdings Inc.
- SEC Form S-3 filed by Creative Medical Technology Holdings Inc.
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Issues Mid-Year Update